24 Mar

International Flavors and Fragrances: Wall Street Ratings

WRITTEN BY Peter Neil

Analysts’ recommendations for International Flavors and Fragrances

As of March 23, 2017, 14 brokerage firms were tracking the International Flavors and Fragrances (IFF) stock actively. Among them, 43% of analysts recommend the stock as a “buy,” 50% analysts recommend the stock as a “hold,” and 7% of analysts recommend the stock as a “sell.”

International Flavors and Fragrances: Wall Street Ratings

Analysts’ consensus indicates a 12-month target price of International Flavors and Fragrances at $131.40. However, as of March 23, IFF traded 2.8% above analysts’ consensus.

Many analysts recommend IFF as a “hold”

IFF’s plans to achieve sales of $500 million to $1 billion by 2020 through acquisitions. It has already acquired Fragrance Resources and David Michael, which should contribute to IFF’s revenue growth. Further, better-than-expected 4Q16 earnings could have influenced analysts in recommending a “hold” on IFF.

Recommendations and targets from well-known brokerage firms

Below are some of the recommended target prices from well-known brokerage firms for International Flavors & Fragrances.

  • On February 27, 2017, J.P. Morgan (JPM) rated International Flavors and Fragrances as “Neutral” with a target price of $123, which implies a 12-month potential return of -8.9% over the March 23, 2017, closing price of $135.07.
  • On February 23, 2017, UBS (UBS) rated International Flavors and Fragrances as a “Buy” with a target price of $138, which implies a 12-month potential return of 2.2% over the March 23, 2017, closing price of $135.07.
  • On February 20, 2017, Barclays (BCS) rated International Flavors and Fragrances as “Underweight” with a target price of $112, which implies a 12-month potential return of -17.10% over the March 23, 2017, closing price of $135.07.

Investors can access IFF by investing in the ProShares Ultra Basic Materials (UYM), which has invested 1.3% of its portfolio in IFF as of March 23, 2017.

Latest articles

Harvest Health (HARV) reported its Q3 earnings yesterday. HARV posted revenue of $33.15 million, which was lower than analysts' estimate of $34.18 million.

Apple (AAPL) stock is up almost 68% year-to-date. AAPL has returned 50% in the trailing 12 months and 125% in the last five years.

While the media caters to Millennial preferences, there’s one economic sector that’s shifting to a more seasoned crowd: healthcare stocks.

Despite solid earnings growth this year, Energy Transfer stock fell close to its multiyear lows recently. Could this weakness be seen as an opportunity?

Last week, Duquesne Family Office, managed by Stanley Druckenmiller, filed its Q3 13F with the SEC. We'll look at the fund's top holdings, buys, and sells.

Investors have waited for a peek at Tesla's electric pickup truck. Elon Musk hinted that it has the Porsche 911's performance and the F-150's functionality.